(SYRS) Syros Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Syros Pharmaceuticals | (SYRS) share price targets
Complete technical analysis of Syros Pharmaceuticals (SYRS) by charts plus indicators, forecast predictions and share price targets for Syros Pharmaceuticals (SYRS)
Syros Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-11-15 View latest technical analysis
10 day averaged volume of Syros Pharmaceuticals is 6920340
Date | Daily Closing Price | Open | High | Low | Volume |
15 Fri Nov 2024 | 0.26 | 0.27 | 0.28 | 0.25 | 0.913 times |
14 Thu Nov 2024 | 0.28 | 0.38 | 0.40 | 0.27 | 2.502 times |
13 Wed Nov 2024 | 0.36 | 0.40 | 0.41 | 0.35 | 5.568 times |
12 Tue Nov 2024 | 2.73 | 3.38 | 3.38 | 2.72 | 1.5 times |
11 Mon Nov 2024 | 3.23 | 2.63 | 3.40 | 2.63 | 0.147 times |
08 Fri Nov 2024 | 2.61 | 2.57 | 2.68 | 2.55 | 0.05 times |
07 Thu Nov 2024 | 2.56 | 2.45 | 2.62 | 2.44 | 0.033 times |
06 Wed Nov 2024 | 2.45 | 2.59 | 2.69 | 2.41 | 0.048 times |
05 Tue Nov 2024 | 2.53 | 2.42 | 2.59 | 2.42 | 0.019 times |
04 Mon Nov 2024 | 2.43 | 2.28 | 2.53 | 2.22 | 0.058 times |
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 0.3, for a target of 1.3 or 2.12
Share price targets for Syros Pharmaceuticals (SYRS)
Target Type | Value |
Downside Target | 0.25 |
Upside Target | 1.43 |
Upside Target | 1.48 |
Upside Target | 1.82 |
Upside Target | 1.89 |
Upside Target | 2.00 |
Upside Target | 2.08 |
Upside Target | 2.22 |
Upside Target | 2.30 |
Upside Target | 2.69 |
Upside Target | 2.77 |
Upside Target | 3.40 |
Upside Target | 4.81 |
Upside Target | 6.17 |
Upside Target | 6.93 |
Intraday share price targets for Syros Pharmaceuticals (SYRS)
Target Type | Value |
Downside Intraday Target | -0.79 |
Downside Intraday Target | -1.85 |
Upside Intraday Target | 2.36 |
Upside Intraday Target | 4.45 |
Upside Intraday Target | 1.3 |
Weekly technical analysis of Syros Pharmaceuticals (SYRS)
Date | Weekly Closing Price | Open | High | Low | Volume |
15 Fri Nov 2024 | 0.26 | 2.63 | 3.40 | 0.25 | 51.219 times |
08 Fri Nov 2024 | 2.61 | 2.28 | 2.69 | 2.22 | 0.49 times |
01 Fri Nov 2024 | 2.27 | 2.00 | 2.77 | 2.00 | 0.655 times |
25 Fri Oct 2024 | 2.00 | 1.93 | 2.69 | 1.89 | 5.307 times |
18 Fri Oct 2024 | 1.96 | 1.95 | 2.08 | 1.82 | 1.543 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Syros Pharmaceuticals (SYRS)
Date | Monthly Closing Price | Open | High | Low | Volume |
15 Fri Nov 2024 | 0.26 | 2.07 | 3.40 | 0.25 | 8.393 times |
31 Thu Oct 2024 | 2.52 | 2.10 | 2.77 | 1.82 | 1.313 times |
30 Mon Sep 2024 | 2.15 | 1.60 | 2.30 | 1.43 | 0.598 times |
30 Fri Aug 2024 | 1.64 | 6.02 | 6.17 | 1.48 | 5.899 times |
Scroll below to view daily charts
Price has moved down this month, and volume has increased substantially. This means that the move can continue in coming months.
Indicators analysis of Syros Pharmaceuticals (SYRS)
Price action analysis of Syros Pharmaceuticals ( (SYRS) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Syros Pharmaceuticals ( (SYRS) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Syros Pharmaceuticals ( (SYRS) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Syros Pharmaceuticals ( (SYRS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Syros Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Syros Pharmaceuticals in short term and the sell signal is strong.
Syros Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Syros Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Syros Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.74 and Syros Pharmaceuticals (SYRS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Syros Pharmaceuticals (SYRS) stock. Volume based technical analysis of Syros Pharmaceuticals (SYRS) stock is negative.
Syros Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Syros Pharmaceuticals ( (SYRS) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Syros Pharmaceuticals ( (SYRS) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Syros Pharmaceuticals ( (SYRS) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Syros Pharmaceuticals ( (SYRS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Syros Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Syros Pharmaceuticals in short term and the sell signal is strong.
Syros Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Syros Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Syros Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.74 and Syros Pharmaceuticals (SYRS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Syros Pharmaceuticals (SYRS) stock. Volume based technical analysis of Syros Pharmaceuticals (SYRS) stock is negative.
Syros Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.